Oliver Schlager

Oliver Schlager

Auto-generated profile, based on publicly available information

Oliver Schlager

Division of Angiology, Department of Medicine II, Medical University of Vienna, Vienna, Austria

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 August 2024 in European Heart Journal
Verified
Journal Article
Closed access
LMLucia Mazzolai
Lucia Mazzolai
GTGisela Teixido-Tura
Gisela Teixido-Tura
SLStefano Lanzi
Stefano Lanzi
VBVinko Boc
Vinko Boc
EBEduardo Bossone
Eduardo Bossone
MSMaksym Sokolov
Maksym Sokolov

29 August 2025 in European Heart Journal
Verified
Journal Article
Closed access
JBJulie De Backer
Julie De Backer
Kristina Hermann HaugaaKristina Hermann Haugaa
Kristina Hermann Haugaa
NHNina Eide Hasselberg
Nina Eide Hasselberg
MHMichèle de Hosson
Michèle de Hosson
MBMargarita Brida
Margarita Brida
FZFeruza Zakirova
Feruza Zakirova

10 March 2024 in European Heart Journal
Verified
Journal Article
Closed access
LMLucia Mazzolai
Lucia Mazzolai
JBJill Belch
Jill Belch
MVMaarit Venermo
Maarit Venermo
VAVictor Aboyans
Victor Aboyans
MBMarianne Brodmann
Marianne Brodmann
AVAdriana Visonà
Adriana Visonà
All guidelines worldwide strongly recommend exercise as a pillar of the management of patients affected by lower extremity peripheral artery disease (PAD). Exercise therapy in this setting presents different modalities, and a structured programme provides optimal results. This clinical consensus paper is intended for clinicians to promote and assist for the set-up of comprehensive exercise programmes to best advice in patients with symptomatic chronic PAD. Different exercise training protocols specific for patients with PAD are presented. Data on patient assessment and outcome measures are narratively described based on the current best evidence. The document ends by highlighting disparities in access to supervised exercise programmes across Europe and the series of gaps for evidence requiring further research.

17 August 2023 in Biomedicines
Verified
Journal Article
Open access
PDF file
MPMichael Poledniczek
Michael Poledniczek
CNChristoph Neumayer
Christoph Neumayer
CKChristoph W. Kopp
Christoph W. Kopp
OSOliver Schlager
Oliver Schlager
TGThomas Gremmel
Thomas Gremmel
PWPatricia Pia Wadowski
Patricia Pia Wadowski
Inflammation has a critical role in the development and progression of atherosclerosis. On the molecular level, inflammatory pathways negatively impact endothelial barrier properties and thus, tissue homeostasis. Conformational changes and destruction of the glycocalyx further promote pro-inflammatory pathways also contributing to pro-coagulability and a prothrombotic state. In addition, changes in the extracellular matrix composition lead to (peri-)vascular remodelling and alterations of the vessel wall, e.g., aneurysm formation. Moreover, progressive fibrosis leads to reduced tissue perfusion due to loss of functional capillaries. The present review aims at discussing the molecular and clinical effects of inflammatory processes on the micro- and macrovasculature with a focus on peripheral artery disease.

2 February 2016 in Circulation
Verified
Journal Article
Closed access
PDF file
MMMarkus Mueller
Markus Mueller
MGMichael E. Gschwandtner
Michael E. Gschwandtner
JGJutta Gamper
Jutta Gamper
GGGeorgiana-Aura Giurgea
Georgiana-Aura Giurgea
SCSilvia Charwat-Resl
Silvia Charwat-Resl
OSOliver Schlager
Oliver Schlager
Background—: In incipient Raynaud phenomenon, nailfold capillaroscopy and autoantibody tests are obtained to screen for an emerging connective tissue disease. Whether the presence of abnormal nailfold capillaries and autoantibodies are related to mortality in patients with incipient Raynaud phenomenon is not known. Methods and Results—: In 2958 consecutive patients (78% women, median age 45 years) with incipient Raynaud phenomenon without previously known connective tissue disease, nailfold capillaroscopy and laboratory tests for antinuclear antibodies (ANA) and ANA subsets were obtained at initial presentation. During a median follow-up period of 9.3 years, 227 women (9.9% of female patients) and 129 men (20% of male patients) with Raynaud phenomenon died. In comparison with a demographically matched standard population, survival was poorer in patients with Raynaud phenomenon (log-rank test P <0.0001). In patients with Raynaud phenomenon, mortality was higher in men than in women ( P <0.0001, Cox proportional hazards model). In women, the presence of abnormal nailfold capillaries, ANA, and anti–Scl-70 antibodies were related to an increase in all-cause mortality. The conjoint presence of abnormal nailfold capillaries and autoantibodies was associated with the highest mortality rates. In men, abnormal nailfold capillaries, and ANA and ANA subsets, as well, were not related to survival. In both sexes, patients’ age and serum creatinine were associated with mortality. Conclusions—: In Raynaud phenomenon, male sex, age, and serum creatinine are related to mortality. Abnormal nailfold capillaries and autoantibodies are associated with an increase in all-cause mortality in female patients, but not in male patients with Raynaud phenomenon.

1 November 2025 in Vasa
Verified
Journal Article
Open access
OSOliver Schlager
Oliver Schlager
ECElena Campello
Elena Campello
JMJuraj Madaric
Juraj Madaric
Jill J.F BelchJill J.F Belch
Jill J.F Belch
LMLucia Mazzolai
Lucia Mazzolai
MTMarkus Theurl
Markus Theurl
Summary: The number of endovascular interventional procedures for catheter-based therapy (CBT) of acute venous thromboembolism (VTE), comprising deep vein thrombosis (DVT) and pulmonary embolism (PE), has been increasing over the past years. The development of more efficient thrombectomy systems for CBT of VTE has potentially enhanced the efficacy of interventional treatment of VTE. Nevertheless, indications for CBT of VTE, i.e. catheter-directed thrombolysis (CDT) or catheter-based mechanical thrombus removal, need to be established based on existing data and expert consensus. Vascular experts should be involved in the decision-making process on CBTs in patients with acute VTE, and thrombus removal procedures should be performed in centers with experience in interventional treatment of VTE. This guideline document of the European Society of Vascular Medicine (ESVM) provides recommendations on indications and management of CBT in acute VTE and is endorsed by the European national societies of Vascular Medicine.